Skip to main navigation Skip to search Skip to main content

The Bilirubin Albumin Ratio in the Management of Hyperbilirubinemia in Preterm Infants to Improve Neurodevelopmental Outcome: A Randomized Controlled Trial - BARTrial

  • Christian V. Hulzebos
  • , Peter H. Dijk*
  • , Deirdre E. van Imhoff
  • , Arend F. Bos
  • , Enrico Lopriore
  • , Martin Offringa
  • , Selma A. J. Ruiter
  • , Koen N. J. A. van Braeckel
  • , Paul F. M. Krabbe
  • , Elise H. Quik
  • , Letty van Toledo-Eppinga
  • , Debbie H. G. M. Nuytemans
  • , Aleid G. van Wassenaer-Leemhuis
  • , Manon J. N. Benders
  • , Karen K. M. Korbeeck-van Hof
  • , Richard A. van Lingen
  • , Liesbeth J. M. Groot Jebbink
  • , Djien Liem
  • , Petri Mansvelt
  • , Jan Buijs
  • Paul Govaert, Ineke van Vliet, Twan L. M. Mulder, Cecile Wolfs, Willem P. F. Fetter, Celeste Laarman
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'The Bilirubin Albumin Ratio in the Management of Hyperbilirubinemia in Preterm Infants to Improve Neurodevelopmental Outcome: A Randomized Controlled Trial - BARTrial'. Together they form a unique fingerprint.
Sort by

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science